Imaging AI in Ohio

Riverain Technologies is a medical software company specializing in artificial intelligence solutions for cardiothoracic imaging interpretation. The company develops the ClearRead product suite, which includes ClearRead CT Chest and ClearRead Xray—AI-powered diagnostic tools designed to streamline chest CT and X-ray reading workflows while improving diagnostic accuracy and clinician confidence. ClearRead CT targets pulmonary nodule detection and coronary artery calcification (CAC) scoring in chest CT examinations. ClearRead Xray provides bone-suppression imaging and detection capabilities for pulmonary nodules and pneumothorax on chest radiographs. The solutions are built on advanced deep-learning algorithms that quantify population health metrics and reduce cognitive burden on radiologists. Riverain serves over 400 customer locations globally, including major academic medical centers (Cleveland Clinic, Duke Health, University of Chicago Medicine, University Hospital Zurich, UW Health), health systems (Northwestern Medicine, Cedars-Sinai, VA), and diagnostic imaging practices. The company emphasizes clinical validation through peer-reviewed publications, case studies, and real-world deployment across international healthcare institutions. Riverain's focus is on improving patient outcomes in lung cancer screening and early detection, pneumothorax identification, and cardiovascular risk assessment through workflow optimization and decision support.

Nano4Imaging GmbH is a medtech company specializing in interventional MRI (iMRI) solutions that transform MRI from a purely diagnostic tool into a fully capable interventional platform. The company develops the trackr. technology ecosystem, which comprises three integrated components: EmeryGlide (an FDA-cleared, MRI-conditional, metal-free guidewire with nanoparticle coating for real-time visualization across all imaging modalities); Magnafy (an advanced multimodal nanoparticle composite applicable to any device for discrete marker visualization in MRI and CT); and trackr.ai (a proprietary deep learning algorithm that provides real-time, radiation-free catheter navigation with GPS-like tracking capability). The platform enables physicians to perform safe, precise interventions without ionizing radiation or nephrotoxic contrast agents, supporting diagnostic and therapeutic procedures in cardiology, particularly right and left heart catheterization and congenital heart disease management. Clinical evidence documents over 200 patients treated with zero procedural complications. The company has demonstrated 250 successful right heart catheterizations for pulmonary pressure assessment. Nano4Imaging collaborates with leading healthcare institutions across Europe and North America. The company was recognized among the top 3% European innovators by the European Innovation Council and received an Accelerator Grant for breakthrough technology potential. EmeryGlide is the world's first FDA-cleared MRI-compatible guidewire and is labeled MR conditional per ASTM standards F2182, F2052, F2053, and F2213. The company continuously expands its portfolio with MRI-compatible catheters and accessory tools.

MediView XR, Inc. is a clinical augmented reality med-tech company specializing in first-in-class AR-powered visualization and navigation solutions for image-guided surgical and interventional procedures. The company develops mixed-reality platforms that overlay real-time 3D anatomical data, live ultrasound imaging, and procedural guidance directly into the surgeon's field of view via holographic heads-up displays. MediView's flagship products—OmnifyXR® Interventional Suite and XR90™ Holographic Surgical Navigation System—enable minimally invasive, ultrasound-guided soft tissue and bone procedures with improved ergonomics, workflow efficiency, spatial visualization depth, and real-time collaborative remote consultation and proctoring capabilities. The XR90 is FDA 510(k)-cleared and integrates seamlessly with GE HealthCare's Allia interventional imaging platform. Primary markets include interventional radiology, minimally invasive surgery, orthopedic surgery, and urological procedures. The company partners with leading academic medical centers and hospitals including The Cleveland Clinic, Mayo Clinic, NewYork Presbyterian/Weill Cornell Medicine, Memorial Sloan Kettering, and Ohio State University. MediView is Microsoft Gold partner and member of the American Medical Extended Reality Association. Recent Series A funding of $24M was led by GE HealthCare, Mayo Clinic, and Cleveland Clinic.

Hyland Software is a global enterprise content management (ECM) and process management platform provider headquartered in Westlake, Ohio. The company delivers AI-enabled Content Innovation Cloud solutions that help healthcare systems, payers, financial services, insurance, government, and other enterprises manage documents, workflows, and enterprise imaging. Key offerings include OnBase (document handling and workflow automation), Perceptive Content, Alfresco (open-source content services with DOD 5015.02 certification), and Nuxeo (digital asset and content management). Hyland's healthcare-specific solutions address clinical care (patient records, consent management, enterprise imaging), payers (member experience, workflow automation), and back-office operations. The platform integrates with core systems, leverages AI for content intelligence and agentic document processing, and supports governed automation across regulated industries. With 3,750+ employees and presence in 25+ countries, Hyland serves more than half of the Fortune 100.

MIM Software Inc., a GE HealthCare company founded in 2003, is a vendor-neutral medical imaging software provider serving over 3,300 healthcare organizations globally, including 90% of the world's top 50 hospitals. The company specializes in imaging analysis and clinical workflow software for radiation oncology, nuclear medicine, cardiology, theranostics, neurology, and urology. Key offerings include MIM Encore™ for digital imaging and workflow solutions, AI Auto-Contouring tools for treatment planning, MIM Symphony Dx™ for prostate MRI visualization and analysis, MIM LesionID™ Pro for automated tumor burden analysis, and MIM ComboTherapy™ GYN HDR/EBRT for combined gynecologic cancer treatment planning. Solutions emphasize standardization, automation, and AI-driven enhancements to improve clinical efficiency, patient safety, and precision care delivery across oncology, diagnostic imaging, and specialty medicine applications.

IONIC Health is a health-tech company specializing in automation, integration, and remote operation technologies for diagnostic medicine, particularly medical imaging. Founded in 2019 with headquarters in São José dos Campos, Brazil, and offices in Cleveland, Ohio and Portugal, IONIC Health serves over 90 B2B clients globally, including major diagnostic centers and hospital networks. The company provides comprehensive software and digital solutions designed to improve efficiency, safety, and accessibility in diagnostic imaging workflows. Key offerings include remote teleoperation platforms for imaging devices (MRI, CT, ultrasound), real-time equipment monitoring and analytics, AI-powered structured radiology reporting with speech recognition, and end-to-end integration solutions. IONIC Health leverages advanced technologies including artificial intelligence, machine learning, big data analytics, and voice recognition to enable remote scanning, automated workflows, and intelligent decision support. With CE Mark approval and ISO/IEC 27001 certification, IONIC Health has demonstrated measurable impact: over 1 million exams facilitated, 1 million+ medical reports issued, 300+ devices under teleoperation, and documented customer savings exceeding $20 million. The company serves a diverse network of over 2,500 physicians and continues expanding across Latin America, Europe, and North America.

Surgical Theater, Inc. develops eXperiential Reality (XR) platforms that transform 2D medical imaging (MRI, CT, DTI) into interactive 3D surgical models using AI-driven reconstruction technology. The company serves neurosurgery, spine surgery, and otolaryngology specialties with three primary solutions: PlanXR™ for preoperative surgical planning and rehearsal; Brain STORM™ for epilepsy care management; and SyncAR® (Spine and Cranial variants) for real-time intraoperative augmented reality visualization. Additional products include XR Studio™ for multidisciplinary case reviews and education within XR headsets, and ConveyXR™ for patient engagement and informed consent. The platform enables surgeons to visualize patient-specific anatomy, identify critical structures (nerves, blood vessels), and simulate complex procedures before entering the operating room. Deployed at leading academic medical centers including Mayo Clinic, Stanford, Mount Sinai, Houston Methodist, UCSF, and NYU Langone, among others. The technology derives from advanced flight simulation methodologies applied to surgical visualization. Regulatory status and specific FDA clearances not explicitly stated on fetched content, though clinical research studies referenced. Serves both academic and community hospital markets internationally.